A 1536 colorimetric SPAP reporter assay: Comparison with 96- and 384-well formats

Journal of Biomolecular Screening

Volumn 3, Issue 3, 1998, Pages 217-225

  Comley, John C W ^a   Reeves, Tony ^a   Robinson, Phil ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001234508     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/108705719800300308     Document Type: Article

References (14)

1. Houston, J.G., Banks, M.N. (1997). The chemical-biological interface: developments in automated and miniaturised screening technology. Curr. Opin. Biotechnol. 8:734-740.
2. Heaney, PJ. (1997). A massively parallel microfabricated system for drug discovery. Paper presented at the CHI 4th Annual Conference on High Throughput Screening for Drug Discovery, Arlington, VA, June 25-27, 1997.
3. Knapp, M. (1997). Labchip: Technologies and devices that facilitate the drug discovery process. Paper presented at the IBC Conference on Microtechnologies and Miniaturisation: Tools, Techniques and Novel Applications for the Pharmaceutical Industry, Berlin, Germany, December 8-9, 1997.
4. Burbaum, J.J., Sigal, N.H. (1997). New technologies for high-throughput screening. Curr. Opin. Chem. Biol. 1:72-78.
5. Comley, J.C.W. (1997). HTS miniaturisation; transition to 384 and beyond. Paper presented at the IBC Conference on Microtechnologies and Miniaturisation: Tools, Techniques and Novel Applications for the Pharmaceutical Industry. Berlin, Germany, December 8-9, 1997.
6. Parandoosh, Z. (1997). Point-counterpoint. Cell-based assays. J. Biomol. Screening. 2:201-202.
7. Giuliano. K.A., DeBiasio, R.L., Dunlay, T., Gough, A., Volosky, J.M., Zock, J., Pavlakis, G.N., Taylor, D.L. (1997). High-content screening: A new approach to easing the bottlenecks in the drug discovery process. J. Biomol. Screening. 2:249-259.
8. Palmer, M. Tillotson, B., Martin, D., Aristarkhov, A., Carson, N., Bronstein, I. (1997). Meeting the need in pharmaceutical screening: An assay development service. Poster presented at the Society for Biomolecular Screening, 3rd Annual Conference and Exhibition. San Diego, CA, September 22-25, 1997.
9. Ray, K.P., Farrow, S., Daly, M., Talabot, R, Searle, N. (1997). Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor a, and inhibition by glucocorticoids. Biochem. J. 328:707-715.
10. Robinson, P., Mander, T. (unpublished results).
11. Wingfield, P., Payton, M., Tavernier, J., Barnes, M., Shaw, A., Rose, K., Simona, M.G., Demczuk, S., Williamson, K., Dayer, J.M. (1986). Purification and characterisation of human inter-leukin-1 beta expressed in recombinant Escherichia coli. Eur. J. Biochem. 160:491-497.
12. Pfaff, M., Reinhardt, O.P., Sakai, L.Y., Timpl, R. (1996). Cell adhesion and integrin binding to recombinant human fibrillin-1. FEBS Lett. 384:247-250.
13. Comley, J.C.W. (unpublished results).
14. Burbaum, J.J. (1998). Miniaturization technologies in HTS: How fast, how small, how soon? Drug Discovery Today. 3:313-322.